Summit Global Investments Merck & Co., Inc. Transaction History

Summit Global Investments

$1.34 Billion
Q1 2024

A detailed history of Summit Global Investments transactions in Merck & Co., Inc. stock. As of the latest transaction made, Summit Global Investments holds 120,547 shares of MRK stock, worth $14.9 Million. This represents 1.18% of its overall portfolio holdings.

Number of Shares

120,547

Previous 205,106 41.23%

Holding current value

$14.9 Million

Previous $22.4 Million 28.87%

% of portfolio

1.18%

Previous 1.46%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$113.24 - $131.95 $9.58 Million - $11.2 Million	-84,559 Reduced 41.23%	120,547 $15.9 Million
Q4 2023 Feb 06, 2024	BUY	$100.18 - $109.02 $3.86 Million - $4.2 Million	38,497 Added 23.11%	205,106 $22.4 Million
Q3 2023 Oct 13, 2023	SELL	$102.95 - $114.33 $290,936 - $323,096	-2,826 Reduced 1.67%	166,609 $17.2 Million
Q2 2023 Jul 18, 2023	SELL	$108.61 - $118.38 $545,222 - $594,267	-5,020 Reduced 2.88%	169,435 $19.6 Million
Q1 2023 May 04, 2023	SELL	$102.94 - $114.86 $2.92 Million - $3.26 Million	-28,378 Reduced 13.99%	174,455 $18.6 Million

Q4 2022 Jan 31, 2023	SELL	$87.44 - $112.11 $322,741 - $413,798	-3,691 Reduced 1.79%	202,833 $22.5 Million
Q3 2022 Nov 14, 2022	BUY	$84.53 - $94.96 $30,515 - $34,280	361 Added 0.18%	206,524 $17.8 Million
Q2 2022 Aug 23, 2022	SELL	$83.49 - $94.64 $4.9 Million - $5.56 Million	-58,698 Reduced 22.16%	206,163 $18.8 Million
Q1 2022 Apr 29, 2022	BUY	$73.51 - $82.4 $8.34 Million - $9.35 Million	113,497 Added 74.98%	264,861 $21.7 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $3.67 Million - $4.6 Million	50,826 Added 50.55%	151,364 $11.6 Million
Q3 2021 Nov 08, 2021	SELL	$71.68 - $78.83 $4.54 Million - $5 Million	-63,382 Reduced 38.67%	100,538 $7.55 Million
Q2 2021 Jan 28, 2022	SELL	$70.31 - $77.77 $315,762 - $349,265	-4,491 Reduced 2.67%	163,920 $12.7 Million
Q1 2021 Jan 27, 2022	SELL	$68.86 - $81.11 $1.99 Million - $2.34 Million	-28,834 Reduced 14.62%	168,411 $13 Million
Q4 2020 Feb 11, 2021	BUY	$71.77 - $79.65 $626,982 - $695,822	8,736 Added 4.63%	197,245 $16.1 Million
Q3 2020 Nov 16, 2020	SELL	$73.18 - $82.95 $173,656 - $196,840	-2,373 Reduced 1.24%	188,509 $15.6 Million
Q2 2020 Aug 11, 2020	BUY	$70.42 - $80.13 $11.5 Million - $13.1 Million	162,865 Added 581.31%	190,882 $14.8 Million
Q1 2020 May 14, 2020	BUY	$63.36 - $87.82 $1.17 Million - $1.62 Million	18,421 Added 191.97%	28,017 $2.16 Million
Q4 2019 Feb 13, 2020	BUY	$77.58 - $87.54 $54,306 - $61,278	700 Added 7.87%	9,596 $873,000
Q3 2019 Nov 08, 2019	SELL	$76.08 - $82.93 $24,497 - $26,703	-322 Reduced 3.49%	8,896 $749,000
Q2 2019 Aug 16, 2019	BUY	$69.84 - $81.59 $643,785 - $752,096	9,218 New	9,218 $773,000
Q2 2018 Aug 10, 2018	SELL	$50.83 - $59.72 $1.02 Million - $1.2 Million	-20,083 Closed	0 $0
Q1 2018 May 03, 2018	SELL	$50.96 - $59.23 $25,785 - $29,970	-506 Reduced 2.46%	20,083 $1.09 Million
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $1.06 Million - $1.27 Million	20,589	20,589 $1.16 Million

Others Institutions Holding MRK

# of Institutions

3,766

Shares Held

1.87B

Call Options Held

17.3M

Put Options Held

14.8M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $314B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

News

Stay updated on Summit Global Investments with notifications on news.

Account

Summit Global Investments Merck & Co., Inc. Transaction History